Efficacy studies on a canarypox-rabies recombinant virus

Vaccine. 1991 Mar;9(3):190-3. doi: 10.1016/0264-410x(91)90152-v.

Abstract

Recombinant avipox viruses have been developed expressing the rabies glycoprotein gene. A fowlpox-rabies recombinant has previously been shown to be protective against live rabies virus challenge in a number of non-avian species. This report describes the development of a canarypox-rabies recombinant. A comparison is made of the protective efficacy of this recombinant with other pox-rabies recombinants.

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Cats
  • DNA, Recombinant
  • Dogs
  • Mice
  • Poxviridae / genetics*
  • Poxviridae / immunology
  • Rabies / prevention & control*
  • Rabies virus / genetics
  • Rabies virus / immunology*
  • Vaccines, Synthetic / immunology
  • Viral Vaccines* / immunology

Substances

  • Antibodies, Viral
  • DNA, Recombinant
  • Vaccines, Synthetic
  • Viral Vaccines